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March 30, 2010:1396–400djudication of the “cardiac mortality” events (6.8% vs. 1.9%, p 
.08) as well as the long-term mortality data in this elderly cohort
ith multiple comorbidities.
The paper leaves us with a few unsettled issues. 1) Are we
upposed to endorse near-complete revascularization merely
ased on coronary angiography and in the absence of supportive
nformation regarding the clinical significance of the lesions and
he documentation of ischemia and viability in the segments
ndergoing revascularization? Were these data obtained at any
tage on any of the “systemic strategy” patients? 2) Is the RCRI
2 a sufficient predictor of events in patients undergoing major
ascular surgery to undergo mandatory coronary angiography?
his is not supported by the CARP (Coronary Artery Revas-
ularization Prophylaxis) data, which showed that coronary
evascularization did not impart a survival benefit in patients
ith higher RCRI (n  248; odds ratio: 1.2, 95% confidence
nterval: 0.76 to 1.89); however, revascularization seemed to
avorably affect long-term survival in patients with large perfu-
ion defects (n  37; odds ratio: 3.96, 95% confidence interval:
.82 to 19.11) (5). Indeed, other predictors of mortality
merged from the CARP trial (5). 3) Are bare-metal stents the
referred mode for multivessel percutaneous coronary interven-
ion in a cohort that is composed of 38.8% to 37.1% diabetic
atients? 4) Were there no vascular, bleeding, and renal
omplications during or after both angiography and revascular-
zation procedures in this senior cohort (mean age 74 years)
ith peripheral vascular disease with a high proportion of
iabetes mellitus and renal insufficiency (more than one-third of
he patients had creatinine 1.7 mg/dl)?
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niversity Hospital UMDNJ
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351:2795–804.re Long-Term Outcomes of
edium- to High-Risk Patients
ndergoing Vascular Surgery
ffected by the Ischemia
valuation Strategy?
n their recently published paper, Monaco et al. (1) examined the
fficacy of 2 different strategies for pre-operative risk stratification
n patients requiring vascular surgery. The selective strategy used
oninvasive testing for ischemia followed by angiography in
atients identified as potential high-risk surgical candidates. The
ystematic strategy used coronary angiography as the primary
eans of risk stratification. In medium- to high-risk patients, the
uthors conclude that routine coronary angiography produced
etter long-term outcomes. Similar to this study, 2 previous
andomized controlled trials have reported no difference in 30-day
ost-operative outcomes (2,3). In contrast to the results from
onaco et al. (1), neither trial reported any long-term benefit from
re-operative coronary revascularization.
We believe that the discrepant result between Monaco et al. (1)
nd the previous trials may be due to the methodology used in the
resent study. All patients, regardless of randomization, received
eta-adrenergic receptor antagonists, and doses in both groups
ere titrated to achieve a resting heart rate 60 beats/min. Only
hen did the patients in the selective strategy group undergo
ipyridamole–thallium scintigraphy or dobutamine stress echocar-
iography. Both the presence and severity of coronary artery
isease are underestimated in patients receiving beta-blocker
herapy before vasodilator myocardial perfusion imaging (4–6).
eta-blockade has also been reported to reduce the sensitivity and
everity of detection of coronary artery stenosis during dobutamine
tress echocardiography (7–9). The ubiquitous use of beta-
lockade in Monaco et al. (1), while clinically appropriate, may
ave produced false negative results within the selective strategy
rm, and limited the accurate detection of high-risk patients
ithin that group.
Such a result would grant an illusory advantage to the
ystematic strategy. To date, there is still no convincing
vidence that pre-operative coronary revascularization before
ascular surgery improves 30-day post-operative outcomes.
niversal angiography for risk stratification of patients requir-
ng vascular surgery deserves further careful investigation before
outine adoption can be supported.
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eply
e read the thoughtful comments of Dr. Rott, Dr. Kaluski, and
r. Pullatt and colleagues on our paper (1) with interest. Surgical
yocardial revascularization was preferred for diabetic patients
ecause the off-pump technique greatly reduces the incidence of
ost-operative bleeding and renal failure. We routinely used
are-metal stents to avoid the substantial risk of thromboses of
rug-eluting stents by employing them in diabetic patients only for
ircumflex or right coronary arteries sized 2.5 mm. Our strategy
f continuing acetylsalicylic acid therapy plus low-molecular-
eight heparin, withdrawing ticlopidine or clopidogrel 1 week
efore planned vascular surgery, has been successful in reducing the
ncidence of perioperative cardiovascular events and post-operative
leeding.
We agree that the stress tests used in our study have excellent
egative predictive values; nevertheless, the vascular patients are a
ypical cohort that often exhibits negative stress test results (see
eferences 31 to 35 in our study). As reported, our study limits are
he lack of both investigator blinding and an independent events
djudication committee. However, we believe that the choice of
nd points, as the major adverse cardiovascular events, including
ardiac-related death and the long-term follow-up should reduce
hese limitations. The revised cardiac risk index (RCRI) is a widely
ccepted predictor of mortality; we routinely use it for its simplicity
nd reliability.
In our opinion, the use of beta-blockers for major vascular
atients is clinically appropriate, but we agree that our ubiquitous
se may have produced false negative results. However, vascular
atients are often elderly, with frequent comorbidities, and so theyre less likely to be left off drugs to undergo diagnostic tests.
aradoxically, in these patients, it is more likely to be performed
or pre-operative coronary angiography and vascular angiography
n the same session.
Finally, from January 2005 through December 2008, we applied
ur systematic strategy to all medium-high risk vascular patients,
nd the results were most encouraging: of 217 patients with RCRI
2 who underwent surgery, we observed a 2.3% (5 of 217) global
0-day incidence of major adverse cardiovascular events, with a
ardiovascular-related mortality of 0.9% (2 of 217).
In conclusion, randomized controlled trials provide reliable
vidence of treatment effects, but their role in routine clinical
ractice may be unclear (2,3). We think that the main message of
ur paper has been misunderstood: comments have focused on the
mpact of prophylactic myocardial revascularization, citing the
ARP (Coronary Artery Revascularization Prophylaxis) trial and
he DECREASE-V (Dutch Echocardiographic Cardiac Risk
valuation Applying Stress Echocardiography) study, and have
verlooked the substantial criticisms already expressed in our
aper. A recent meta-analysis of these randomized trials shows
hat coronary artery bypass graft may improve long-term outcomes
n vascular surgical patients (4). The systematic strategy adopted of
rophylactic coronary angiography (we underline that it is per-
ormed together with peripheral angiography, as part of standard
iagnostic workup), identifies with certainty all coronary artery
isease patients and allows the cardiovascular surgeon and referring
hysician to treat them appropriately, thus improving patients’
ife-long adherence to correct lifestyle and medications regimens.
ascular patients must be considered as cardiovascular patients (5).
he conceptual unification of cardiac and vascular diseases would
nduce cardiac surgeons, vascular surgeons, and cardiologists to
mprove their relationship, thus ameliorating the outcome of such
omplex patients.
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